{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:51:40Z","timestamp":1793278300682,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1218,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004941","name":"Guy's and St Thomas' NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010872","name":"King's College Hospital NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/jid.2012.106","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T08:26:19Z","timestamp":1334219179000},"page":"2042-2049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Regulation of T-Plastin Expression by Promoter Hypomethylation in Primary Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"132","author":[{"given":"Christine L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.T.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Caesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.106_bb0010","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2012.106_bb0015","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V97.5.1388","article-title":"CD4 (+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor","volume":"97","author":"Bagot","year":"2001","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.leu.2405044","article-title":"S\u00e9zary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3","volume":"22","author":"Booken","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/jid.2012.106_bb0025","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.leu.2403263","article-title":"Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia","volume":"18","author":"Bruggemann","year":"2004","journal-title":"Leukemia"},{"key":"10.1038\/jid.2012.106_bb0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0040","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/10428190802064917","article-title":"Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma","volume":"49","author":"Capriotti","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/jid.2012.106_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1074-7613(03)00172-9","article-title":"Role for plastin in host defense distinguishes integrin signaling from cell adhesion and spreading","volume":"19","author":"Chen","year":"2003","journal-title":"Immunity"},{"key":"10.1038\/jid.2012.106_bb0050","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2007-08-109074","article-title":"Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression","volume":"111","author":"Contassot","year":"2008","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0055","author":"Drummond"},{"key":"10.1038\/jid.2012.106_bb0060","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/ijc.21593","article-title":"The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cells","volume":"118","author":"Foran","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2012.106_bb0065","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/1097-0142(20011001)92:7<1745::AID-CNCR1689>3.0.CO;2-0","article-title":"Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sezary syndrome","volume":"92","author":"Fraser-Andrews","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/jid.2012.106_bb0070","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM198105283042202","article-title":"Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells","volume":"304","author":"Haynes","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2012.106_bb0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1006\/bbrc.1998.8978","article-title":"Search for genes involved in UV-resistance in human cells by mRNA differential display: increased transcriptional expression of nucleophosmin and T-plastin genes in association with the resistance","volume":"248","author":"Higuchi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/jid.2012.106_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(96)01150-7","article-title":"Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display","volume":"397","author":"Hisano","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1038\/jid.2012.106_bb0085","first-page":"933","article-title":"The role of T-fimbrin in the response to DNA damage: silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents","volume":"27","author":"Ikeda","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1038\/jid.2012.106_bb0090","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/jid.2009.301","article-title":"Downregulation of Fas gene expression in Sezary syndrome is associated with promoter hypermethylation","volume":"130","author":"Jones","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.106_bb0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood","volume":"115","author":"Jones","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2012.106_bb0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20021726","article-title":"Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma","volume":"197","author":"Kari","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2012.106_bb0105","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2133.2008.08739.x","article-title":"The diagnosis of S\u00e9zary syndrome on peripheral blood by flow cytometry requires the use of multiple markers","volume":"159","author":"Klemke","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.106_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/104454999315592","article-title":"Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island","volume":"18","author":"Lin","year":"1999","journal-title":"DNA Cell Biol"},{"key":"10.1038\/jid.2012.106_bb0115","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/S0021-9258(18)53842-4","article-title":"Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells","volume":"268","author":"Lin","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.106_bb0120","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2005-07-2813","article-title":"Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy","volume":"107","author":"Nebozhyn","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"10.1038\/jid.2012.106_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.1587","article-title":"Increased expression of T-fimbrin gene after DNA damage in CHO cells and inactivation of T-fimbrin by CpG methylation in human colorectal cancer cells","volume":"97","author":"Sasaki","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2012.106_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.leukres.2008.06.025","article-title":"Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in S\u00e9zary syndrome","volume":"33","author":"Steinhoff","year":"2009","journal-title":"Leuk Res"},{"key":"10.1038\/jid.2012.106_bb0140","first-page":"7122","article-title":"Aberrant expression of T-plastin in Sezary cells","volume":"63","author":"Su","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.106_bb0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.2009.09587.x","article-title":"T-plastin (PLS3) gene expression differentiates Sezary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression","volume":"162","author":"Tang","year":"2010","journal-title":"The British journal of dermatology"},{"key":"10.1038\/jid.2012.106_bb0150","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.jid.5700371","article-title":"Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma","volume":"126","author":"Tiemessen","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.106_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-59745-418-6_7","article-title":"MRD detection in acute lymphoblastic leukemia patients using Ig\/TCR gene rearrangements as targets for real-time quantitative PCR","volume":"538","author":"van der Velden","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1038\/jid.2012.106_bb0160","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","article-title":"Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in S\u00e9zary syndrome identified by gene expression analysis","volume":"64","author":"van Doorn","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.106_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404467","article-title":"Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936","volume":"21","author":"van Krieken","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/jid.2012.106_bb0170","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/eji.200636320","article-title":"Costimulation induced phosphorylation of L-plastin facilitates surface transport of the T cell activation molecules CD69 and CD25","volume":"37","author":"Wabnitz","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1038\/jid.2012.106_bb0175","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0180","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1038\/jid.2012.106_bb0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.jid.5701027","article-title":"IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with S\u00e9zary syndrome","volume":"128","author":"Yoon","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15358413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15358413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:11:46Z","timestamp":1743963106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15358413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022202X15358413"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.106","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of T-Plastin Expression by Promoter Hypomethylation in Primary Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}